Flourish Research - San Antonio

Heart Disease Self-Scheduler

Basic Criteria: 

  • Be 18+ with at least one of the following. 
    • Coronary artery disease (CAD) 
    • Heart attack 
    • Coronary artery score (CAC) >400 
    • History of surgical or percutaneous coronary revascularization procedure. Examples: Coronary Artery Bypass grafting, Percutaneous Coronary Interventintion, Endarterectomy, Transmyocardial laser Revascularization  
    • Stroke (ischemic, hemorrhagic or unknow type) 
    • Peripheral arterial disease (PAD) defined as either intermittent claudication within the last 12months OR prior nontraumatic amputation or peripheral procedure (stenting or surgical revascularization)  

OR 

  • Be 55+ with high risk for CVD with at least 2 of the following  
    • Age ≥ 70 years  
    • Chronic kidney Disease  eGFR <60 
    • Current smoker-clarify 
    • AFIB and on medical therapy (anticoagulation or rate control) 
    • Most recent CAC score >100 
    • Type 1 or 2 diabetes, BMI≥ 30 or BMI ≥ 27 if East Asian, South East Asian or South Asian decent 
    • Treated high blood pressure, on a stable dose for 30days with a thiazide, thiazide-like or loop diuretic AND at least one other standard care of Blood pressure meds for any of these drug classes: ACE inhibitor or ARB, Calcium channel blocker, Beta blocker, MRA, Vasodilator (hydralazine, minoxidil, alpha blocker) or centrally acting antihypertensive medication (e.g. clonidine)  
    • Blood pressure range ≥ 145mmHg and <180mmHg Systolic

Answers Must Be No: 

  • If female of childbearing potential, are you currently pregnant, breastfeeding, or planning to become pregnant?   
  • In the past 12months have you had any alcohol or substance use disorder? 
  • Are you currently taking both an ARB and an ACE inhibitor (either as a single medication or part of combination medications? 
  • Is your high blood pressure because of other conditions including but not limited to history of renovascular hypertension, primary aldosteronism, pheochromocytoma, Cushing syndrome, or aortic coarctation? 
    • Exception: high blood pressure due to CKD. 
  • Do you have a condition where blood pressure drops significantly when a person stands up from a sitting or lying position? 
  • If diabetic, have you had an A1C >10 % in the past 2 months? 
  • Have you lost >10% of weight in the past 3months? Patients on drugs that cause significant weight loss like GLP-1 must be on stable dose for at least 3months. 
  • Do you have any history of or current liver cirrhosis? 
  • Do you have any active HIV infection? Exception: Patients on antiretroviral clinical stable and compliant with treatment for at least 6months 
  • Have you received any investigation product in the past 30days? 
  • In the past 3 months, have you used a potassium binder for the treatment of hyperkalemia? 
  • Do you have any sever respiratory disease, NYHA class IV heart failure, cancer in the past 5 years or any other condition that could limit participation for the duration of the study? Exception: non-melanoma skin cancer 
  • Have you undergone major organ transplant or anticipate doing so during the study? 
  • In the past 6 months, have you been treated or anticipate being treated with any therapeutic agent that targets AGT? Examples:  Cozaar, Benicar, Atacand, Diovan, Avapro, Micardis ,Edarbi 
  • Do you have any current or history of severe intolerance (e.g. angioedema, recurrent hyperkalemia, recurrent acute kidney injury) to an ARB or ACE inhibitor other than cough?  
  • Have you had any significant CV events like heart attack, stroke, revascularization procedure or been hospitalized for heart failure in the past 60 days? 
  • Do you have severe aortic stenosis, a condition where the aortic valve controlling blood from the heart to the body becomes narrowed and does not open properly? 
  • Are you currently placed in an institution based on an official or court order? 

Answers Must be YES 

  • Are you able to sign consent and comply with all study requirements? 
  • If female of childbearing potential, do you agree to use a highly effective method of contraception as listed below from at least 1 prior completed menstrual cycle through 12months after last dose administration?  
    • Oral, Implantable, transdermal, injectable methods associated with inhibition of ovulation 
    • Intrauterine device (IUD)  
    • Intrauterine hormone-releasing system (IUS)  
    • Bilateral tubal occlusion 
    • Have a partner who is vasectomized or sterile due to medical cause. Must bring documentation. 
    • Sexual abstinence if preferred and usual lifestyle 
  • If female of non-childbearing potential, do you meet one of the following requirements? 
    • Postmenopausal defined as no cycle for 12 months without an alternative medical cause.  
    • Documented: hysterectomy, bilateral salpingectomy, bilateral oophorectomy 

  Additional criteria will apply 

Compensation up to $1,150 may be available for time and travel

Insurance is not required 

PLEASE NOTE: If you do not see an available appointment, please call 210-714-0067 for availability

Schedule Appointment
Flourish Research News

Stay current with the latest clinical trial news and learn how Flourish Research is supporting the advancement of life-changing therapeutics.